impairment of assets Reported net loss of THB 388mn, mainly from loss on impairment of assets totaling THB 355mn. Excluding this and other one-off items totaling THB 43mn, Recurring net profit stood at THB
, Structural Improvements, Enhanced Portfolio, New Investment Strategy In 2018: Revenue $10.7 billion, +27% YoY Core EBITDA of $1.4 billion, +44% YoY, Core EBITDA margin 13% Net Profit (after Tax/NCI) of
War trade crisis between USA and China which were heavy retaliate. China’s currency has weakened to lower than 7 Yuan per 1 USD that is the first time in 11 years after USA announce to increasing the
compared to Q1 2017 of 817 million Baht, comprising of: (1) gross profit from property business of 156 million Baht (29% of total revenues from property business); significantly decreased by 70% as compared
% Selling and administrative expenses 3,213.5 2,062.2 55.8% 969.9 825.1 17.5% Loss on impairment of assets 355.0 781.5 (54.6)% 0.0 355.0 (100.0)% EBITDA 976.5 144.0 578.0% 319.5 (19.0) N.A. Share of profit
medicines, expanding various product types, increasing revenue and reducing costs Agenda 4 To consider and approve the issuance and offering of debentures in an amount not exceeding 300 million Baht. The
and its Subsidiaries Million Baht Item Quarter Change (%) 9 Months Change 3/2017 2/2017 3/2016 2/2017 3/2016 2017 2016 (%) Net profit * 8.161 8,047 8,061 1.4% 1.2% 24,513 23,547 4.1% Earnings per share
, increasing slightly from 0.76 percent in the second quarter. The average exchange rate was 32.97 THB/USD, appreciating from 33.39 THB/USD in the same period last year but weaker than 31.92 THB/USD in the
and subsidiaries reported Baht 9,744 million in net profit, decreasing Baht 1,173 million or 10.75 percent over-quarter. The decrease could be attributed to non-interest income, which dropped Baht 3,187